Washington settles generic drug cases with Ascend Laboratories, Citron Pharma, and Mayne Pharma
Washington, as part of a bipartisan coalition of 45 states and territories, has reached settlements with Ascend Laboratories, Citron Pharma and Mayne Pharma to resolve allegations the generic drug manufacturers engaged in a long-running conspiracy to artificially inflate and manipulate prices and reduce competition.
Other Languages